207 related articles for article (PubMed ID: 22408061)
1. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations.
Johnson DE; Drummond E; Grimwood S; Sawant-Basak A; Miller E; Tseng E; McDowell LL; Vanase-Frawley MA; Fisher KE; Rubitski DM; Stutzman-Engwall KJ; Nelson RT; Horner WE; Gorczyca RR; Hajos M; Siok CJ
J Pharmacol Exp Ther; 2012 Jun; 341(3):681-91. PubMed ID: 22408061
[TBL] [Abstract][Full Text] [Related]
2. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
[TBL] [Abstract][Full Text] [Related]
3. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
Nair SG; Gudelsky GA
Synapse; 2004 Sep; 53(4):202-7. PubMed ID: 15266551
[TBL] [Abstract][Full Text] [Related]
4. 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.
Cachard-Chastel M; Lezoualc'h F; Dewachter I; Deloménie C; Croes S; Devijver H; Langlois M; Van Leuven F; Sicsic S; Gardier AM
Br J Pharmacol; 2007 Apr; 150(7):883-92. PubMed ID: 17325649
[TBL] [Abstract][Full Text] [Related]
5. Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease.
Spencer JP; Brown JT; Richardson JC; Medhurst AD; Sehmi SS; Calver AR; Randall AD
Neuroscience; 2004; 129(1):49-54. PubMed ID: 15489027
[TBL] [Abstract][Full Text] [Related]
6. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
7. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
9. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
Laplante F; Srivastava LK; Quirion R
J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a sample stabilization strategy and a UPLC-MS/MS method for the simultaneous quantitation of acetylcholine (ACh), histamine (HA), and its metabolites in rat cerebrospinal fluid (CSF).
Zhang Y; Tingley FD; Tseng E; Tella M; Yang X; Groeber E; Liu J; Li W; Schmidt CJ; Steenwyk R
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2023-33. PubMed ID: 21684223
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
12. The facilitating effect of prucalopride on cholinergic neurotransmission in pig gastric circular muscle is regulated by phosphodiesterase 4.
Priem E; Van Colen I; De Maeyer JH; Lefebvre RA
Neuropharmacology; 2012 Apr; 62(5-6):2126-35. PubMed ID: 22266217
[TBL] [Abstract][Full Text] [Related]
13. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
[TBL] [Abstract][Full Text] [Related]
14. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
[TBL] [Abstract][Full Text] [Related]
15. The selective 5-HT(1A) receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat.
Kehr J; Hu XJ; Yoshitake T; Wang FH; Osborne P; Stenfors C; Ogren SO
Eur Neuropsychopharmacol; 2010 Jul; 20(7):487-500. PubMed ID: 20413275
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice.
Rutz S; Riegert C; Rothmaier AK; Buhot MC; Cassel JC; Jackisch R
Brain Res Bull; 2006 Jun; 70(1):81-93. PubMed ID: 16750486
[TBL] [Abstract][Full Text] [Related]
17. VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.
Mohler EG; Shacham S; Noiman S; Lezoualc'h F; Robert S; Gastineau M; Rutkowski J; Marantz Y; Dumuis A; Bockaert J; Gold PE; Ragozzino ME
Neuropharmacology; 2007 Sep; 53(4):563-73. PubMed ID: 17692343
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus.
Herrik KF; Mørk A; Richard N; Bundgaard C; Bastlund JF; de Jong IEM
Neuropharmacology; 2016 Aug; 107():351-363. PubMed ID: 27039041
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
20. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
